Obinutuzumab
Acalabrutinib
(Update) Acalabrutinib in CLL and MCL
Zanubrutinib
CLL Society
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
JNCCN: How To Manage Cancer Care During COVID-19 Pandemic
Leukemia & Lymphoma Society